KIMIA BIOSCIENCES
|
KIMIA BIOSCIENCES Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 2.03 | -1.12 | -1.98 | -0.78 | 1.08 |
| CEPS(Rs) | 2.75 | -0.43 | -1.27 | -0.16 | 1.48 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 2.11 | 0.07 | 1.15 | 3.15 | 3.90 |
| Tax Rate(%) | 29.50 | 26.10 | 24.51 | 26.21 | 7.77 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.03 | -0.46 | -3.96 | 0.51 | 6.31 |
| EBIT Margin(%) | 15.30 | -2.03 | -6.34 | -1.10 | 6.72 |
| Pre Tax Margin(%) | 11.46 | -6.85 | -9.64 | -4.02 | 4.17 |
| PAT Margin (%) | 8.08 | -5.06 | -7.28 | -2.96 | 3.85 |
| Cash Profit Margin (%) | 10.92 | -1.92 | -4.68 | -0.61 | 5.29 |
| Performance Ratios | |||||
| ROA(%) | 9.44 | -5.02 | -8.28 | -3.44 | 5.31 |
| ROE(%) | 186.70 | -183.25 | -91.91 | -22.22 | 32.19 |
| ROCE(%) | 42.18 | -4.18 | -14.30 | -2.32 | 16.13 |
| Asset Turnover(x) | 1.17 | 0.99 | 1.14 | 1.16 | 1.38 |
| Sales/Fixed Asset(x) | 2.39 | 2.25 | 2.85 | 3.18 | 4.68 |
| Working Capital/Sales(x) | -18.20 | -13.06 | 20.24 | 11.08 | 6.92 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.42 | 0.45 | 0.35 | 0.31 | 0.21 |
| Receivable days | 98.68 | 101.18 | 86.33 | 105.16 | 108.76 |
| Inventory Days | 100.34 | 137.54 | 121.06 | 88.70 | 60.51 |
| Payable days | 233.00 | 209.95 | 164.94 | 140.43 | 108.06 |
| Valuation Parameters | |||||
| PER(x) | 20.92 | - | - | - | 35.17 |
| PCE(x) | 15.48 | -130.77 | -25.54 | -233.46 | 25.60 |
| Price/Book(x) | 20.18 | 796.60 | 28.15 | 11.95 | 9.74 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.96 | 2.92 | 1.60 | 1.75 | 1.68 |
| EV/Core EBITDA(x) | 10.80 | 264.63 | -54.80 | 139.42 | 20.56 |
| EV/EBIT(x) | 12.81 | -143.65 | -25.32 | -158.27 | 24.97 |
| EV/CE(x) | 5.48 | 7.01 | 3.53 | 3.93 | 3.52 |
| M Cap / Sales | 1.69 | 2.51 | 1.20 | 1.42 | 1.35 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 13.39 | -18.39 | 2.89 | -5.89 | 24.86 |
| Core EBITDA Growth(%) | 1,762.06 | 130.79 | -340.65 | -85.57 | 100.09 |
| EBIT Growth(%) | 952.49 | 73.79 | -491.19 | -115.43 | 137.67 |
| PAT Growth(%) | 281.07 | 43.24 | -152.56 | -172.55 | 269.62 |
| EPS Growth(%) | 281.08 | 43.24 | -152.55 | -172.55 | 262.17 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 3.27 | 131.12 | 9.69 | 2.73 | 2.44 |
| Current Ratio(x) | 0.92 | 0.88 | 1.08 | 1.18 | 1.38 |
| Quick Ratio(x) | 0.50 | 0.44 | 0.45 | 0.58 | 0.91 |
| Interest Cover(x) | 3.99 | -0.42 | -1.92 | -0.38 | 2.63 |
| Total Debt/Mcap(x) | 0.16 | 0.16 | 0.34 | 0.23 | 0.25 |
Compare Financial Ratios of peers of KIMIA BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KIMIA BIOSCIENCES | ₹156.4 Cr | 3.3% | -2.3% | -29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,077.0 Cr | 2.8% | 6.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,324.0 Cr | -2.1% | -2.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,235.0 Cr | -2.5% | 4.2% | 21.5% | Stock Analytics | |
| CIPLA | ₹123,294.0 Cr | 0% | -3.3% | 0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,336.0 Cr | 1.3% | -0.5% | -0.2% | Stock Analytics | |
KIMIA BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KIMIA BIOSCIENCES | 3.3% |
-2.3% |
-29.3% |
| SENSEX | 0.9% |
2.1% |
8.3% |
You may also like the below Video Courses
